ATE462446T1 - Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen - Google Patents

Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen

Info

Publication number
ATE462446T1
ATE462446T1 AT01905127T AT01905127T ATE462446T1 AT E462446 T1 ATE462446 T1 AT E462446T1 AT 01905127 T AT01905127 T AT 01905127T AT 01905127 T AT01905127 T AT 01905127T AT E462446 T1 ATE462446 T1 AT E462446T1
Authority
AT
Austria
Prior art keywords
administration
composition
vaccine
immunogenic composition
compositions
Prior art date
Application number
AT01905127T
Other languages
English (en)
Inventor
Albert Kapikian
Robert Chanock
Stephen Udem
Timo Vesikari
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE462446T1 publication Critical patent/ATE462446T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01905127T 2000-01-28 2001-01-26 Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen ATE462446T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17868900P 2000-01-28 2000-01-28
PCT/US2001/002686 WO2001054718A2 (en) 2000-01-28 2001-01-26 Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions

Publications (1)

Publication Number Publication Date
ATE462446T1 true ATE462446T1 (de) 2010-04-15

Family

ID=22653531

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01905127T ATE462446T1 (de) 2000-01-28 2001-01-26 Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen

Country Status (7)

Country Link
US (1) US7431931B2 (de)
EP (1) EP1251869B1 (de)
AT (1) ATE462446T1 (de)
AU (1) AU784344B2 (de)
CA (1) CA2398428C (de)
DE (1) DE60141681D1 (de)
WO (1) WO2001054718A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0503337D0 (en) 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
US8168202B2 (en) * 2005-07-07 2012-05-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hexavalent bovine rotavirus reassortant composition designed for use in developing countries
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571385A (en) 1983-06-27 1986-02-18 The United States Of America As Represented By The Department Of Health And Human Services Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors

Also Published As

Publication number Publication date
AU784344B2 (en) 2006-03-16
US20040223981A1 (en) 2004-11-11
DE60141681D1 (de) 2010-05-12
CA2398428A1 (en) 2001-08-02
EP1251869B1 (de) 2010-03-31
WO2001054718A2 (en) 2001-08-02
AU3304001A (en) 2001-08-07
WO2001054718A3 (en) 2002-04-18
US7431931B2 (en) 2008-10-07
EP1251869A2 (de) 2002-10-30
CA2398428C (en) 2015-09-08

Similar Documents

Publication Publication Date Title
JP2012506411A5 (de)
ES2257769T3 (es) Metodo para la preparacion de vacunas multivalentes.
EA200701519A1 (ru) Живая аттенуированная ротавирусная вакцина для перорального введения
NO20015073D0 (no) Vaksiner
SI2473605T1 (en) CEPIVO PCSK9
RU2011120706A (ru) Композиции вакцин, содержащие мутированный белок, связывающий фактор н
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
CA2080477A1 (en) Oral vaccine comprising antigen surface-associated with red blood cells
BR0007936A (pt) Composto, formulação adjuvante imunológica, formulação de vacina, e, processo para estimular uma resposta imune a um antìgeno
BR9915852A (pt) Conjugado de hapteno-portador para tratamento e prevenção do vìcio da nicotina
DK1740217T3 (da) Meningokok-konjugat-vaccination
HUP0401606A2 (hu) West Nile vakcina
MY169275A (en) Method of immunization against the four serotypes of dengue
RU2013119946A (ru) Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал
BRPI0014142B8 (pt) composição de vacina comprimida estável, e, pacote para vacinação
WO2002032923A3 (en) Improved formulations using heat shock/stress protein-peptide complexes
RU2005106234A (ru) Применение ацетата анекортава для защиты остроты зрения пациентов с возрастной дегенерацией желтого пятна
WO2005074460A3 (en) Methods of enhancing immune response in the intradermal compartment and compounds useful in the methods
ATE416788T1 (de) Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme
ATE462446T1 (de) Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen
EA202190778A1 (ru) Композиция комбинированной вакцины, содержащая уменьшенную дозу инактивированного полиовируса, и способ её получения
PT1015595E (pt) Peptidos derivados da proteina de ligacao (g) do virus sincicial respiratorio
WO1999053950A3 (en) Live vaccines and methods of treatment therewith
CA2354045A1 (en) New cancer treatments
AR048671A1 (es) Procedimiento de vacunacion contra la infeccion testicular por bvdv

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties